Viridian Therapeutics Inc (NAS:VRDN)
$ 22.98 -0.12 (-0.52%) Market Cap: 2.60 Bil Enterprise Value: 1.96 Bil PE Ratio: 0 PB Ratio: 4.39 GF Score: 49/100

Viridian Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 03:30 PM GMT
Release Date Price: $30.39 (+3.65%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VRDN.OQ - Viridian Therapeutics Inc
Viridian Therapeutics Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Anything that you're hearing that we should, Yeah.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah. Yeah.

How are you doing?

Yeah.

That's good, but the vibes are good.

Go ahead and get started? Yeah. Awesome.

You can always move some of the chairs too.

Alrighty, I think we'll go ahead and get started. Hi everyone, thank you for joining us in the room and online, for day 3 of TD Cowan's 46th annual healthcare conference. I'm Joe Thom, one of the senior biotech analysts here on the team at TD Cowan
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot